- Previous Close
0.2263 - Open
0.2252 - Bid 0.2252 x 800
- Ask 0.2299 x 1000
- Day's Range
0.2252 - 0.2252 - 52 Week Range
0.1272 - 0.6999 - Volume
15,000 - Avg. Volume
2,232 - Market Cap (intraday)
-- - Beta (5Y Monthly) 2.95
- PE Ratio (TTM)
-- - EPS (TTM)
-2.8430 - Earnings Date Apr 14, 2025 - Apr 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Feb 14, 2022
- 1y Target Est
--
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.
www.ontrakhealth.com102
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OTRKP
View MorePerformance Overview: OTRKP
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OTRKP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OTRKP
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-237.77%
Return on Assets (ttm)
-53.14%
Return on Equity (ttm)
-782.98%
Revenue (ttm)
11.24M
Net Income Avi to Common (ttm)
-35.68M
Diluted EPS (ttm)
-2.8430
Balance Sheet and Cash Flow
Total Cash (mrq)
7.97M
Total Debt/Equity (mrq)
72.47%
Levered Free Cash Flow (ttm)
-12.04M